Passage Bio Inc (PASG) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.66
• Market Cap: $29.63M
• EPS: $-14.62
• 52-Week High: $20.00
• 52-Week Low: $5.12

Market Sentiment

Passage Bio Inc currently has a Bullish sentiment score of 0.28.

About Passage Bio Inc

Passage Bio, Inc. is a leading biotechnology firm dedicated to pioneering gene therapies targeting rare monogenic disorders of the central nervous system. Based in Philadelphia, Pennsylvania, the company utilizes its proprietary adeno-associated virus (AAV) delivery platform to develop groundbreaking treatments that address critical unmet needs in neurology. With a comprehensive pipeline and strategic partnerships, Passage Bio is positioned to significantly influence the evolving landscape of...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Passage Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PASG pay dividends?

Passage Bio Inc (PASG) does not currently pay a regular dividend.

What is PASG's market cap?

Passage Bio Inc (PASG) has a market capitalization of $29.63M with a current stock price of $8.66.